INTERESTING IMAGES

Mol Imaging Radionucl Ther 2017; 26: 116-119
Received Date: 18.04.2017
Accepted Date: 23.06.2017
*

Çukurova University Faculty of Medicine, Department of Nuclear Medicine, Adana, Turkey

**

Çukurova University Faculty of Medicine, Department of Medical Oncology, Adana, Turkey

***

Çukurova University Faculty of Medicine, Department of Radiology, Adana, Turkey

Super Scan Caused by Parathyroid Carcinoma Observed Both in 18F-FDG PET/CT Scan and Tc-99m MDP Bone Scintigraphy

Super scan is a well-known finding described in skeletal scintigraphy characterized by uniform symmetrically increased radiopharmaceutical uptake by bones and consequently diminished renal parenchymal activity. Sy et al. hypothesized that the faint visualization of renal cortex in bone scintigraphy might be the result of increased uptake of radiopharmaceutical by pathologic bones and reduced phosphate excretion. The super scan on 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) has been observed in various conditions such as prostate cancer, lung cancer, renal adenocarcinoma, gastric cancer and primitive neuroectodermal tumor of the kidney. Herein we report the first case of super scan in a 68-year-old-woman with parathyroid carcinoma observed both in 18F-FDG PET/CT and Tc-99m methylene diphosphonate bone scintigraphy. There were extensive hypermetabolic lesions throughout the skeleton in 18F-FDG PET/CT. In contrast to the intense hypermetabolism of the skeleton; the liver, skeletal muscles of the limbs, mediastinum, bowel and especially the brain showed very low FDG uptake. Additionally, there was increased skeletal radiotracer uptake relative to soft tissue, and faint genitourinary tract activity in bone scintigraphy.

Ethics

Informed Consent: Consent form was filled out by all participants.

Peer-review: Internally peer-reviewed.

Authorship Contributions

Surgical and Medical Practices: İ.B.G., S.P., H.T.B., Concept: İ.B.G., S.P., H.T.B., Design: İ.B.G., Data Collection or Processing: İ.B.G., Analysis or Interpretation: İ.B.G., S.P., H.T.B., Literature Search: İ.B.G., Writing: İ.B.G., S.P.

Conflict of Interest: No conflict of interest was declared by the authors.

Financial Disclosure: The authors declared that this study received no financial support.

References

1.    Chew FS, Huang-Hellinger F. Brown tumor. AJR 1993;160:752.
2.    Wiegemann T, Rosenthall L, Kaye M. Technetium-99m-pyrophosphate bone scans in hyperparathyroidism. J Nucl Med 1977;18:231-235.
3.    Buckley O, O’Keeffe S, Geoghegan T, Lyburn ID, Munk PL, Worsley D, Torreggiani WC. 99m Tc bone scintigraphy superscans: a review. Nucl Med Commun 2007;28:521-527.
4.    Frankel RS, Johnson KW, Mabry JJ, Johnston GS. “Normal” bone radionuclide image with diffuse skeletal lymphoma. A case report. Radiology 1974;111:365-366.
5.    Chakraborty PS, Sharma P, Karunanithi S, Bal C, Kumar R. Metastatic superscan on (99m)Tc-MDP bone scintigraphy in a case of carcinoma colon: Common finding but rare etiology. Indian J Nucl Med 2014;29:158-159.
6.    Demir H, Halac M, Gorur GD, Sonmezoglu K, Uslu I. FDG PET/CT findings in primary hyperparathyroidism mimicking multiple bone metastases. Eur J Nucl Med Mol Imaging 2008;35:686.

Home Archive Search Menu